Cell Expansion Market Forecast, Trends, Opportunities And Growth 2025-2034

Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

How Has the Cell Expansion Market Evolved in Terms of Size and Value From 2025 to 2029?
The cell expansion market size has grown rapidly in recent years. It will grow from $28.11 billion in 2024 to $32.31 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to public awareness and acceptance, cell-based research applications, rising demand for cell-based therapies, biopharmaceutical industry growth, regenerative medicine advancements.

The cell expansion market size is expected to see rapid growth in the next few years. It will grow to " $59.31 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to rising investments in biotechnology, expanding stem cell research, clinical trials and drug development, demand for personalized medicine, biobanking and cell repositories. Major trends in the forecast period include technological advancements, product innovations, strategic collaborations.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8264&type=smp

What Are the Dominant Growth Drivers Impacting the Cell Expansion Market Outlook?
The increasing incidence of chronic diseases is expected to propel the demand for cell expansion market going forward. Chronic diseases are long-lasting illnesses that often cannot be healed, however, they are occasionally curable and controllable. Chronic diseases are increasing due to increased use of tobacco products, poor nutrition, physical inactivity, excessive alcohol use, and others. Cell expansion helps replenish nutrients while preventing the accumulation of toxic metabolic waste products that could impair culture performance. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, It is projected that by the year 2050, the number of individuals aged 50 years and above who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, an increase in the incidence of chronic diseases will drive the growth of the cell expansion market.

Which Market Segment Offers the Most Significant Growth Opportunities in the Cell Expansion Market?
The cell expansionmarket covered in this report is segmented –

1) By Cell Type: Mammalian; Microbial; Other Cell Types
2) By Product: Consumables; Reagents; Media; Serum; Disposables; Instruments
3) By Application: Biopharmaceuticals; Tissue Culture And Engineering; Vaccine Production; Drug Development; Gene Therapy; Cancer Research; Stem Cell Research; Other Applications
4) By End-user: Biopharmaceutical And Biotechnology Companies; Research Institutes; Cell Banks; Other End-Users

Subsegments:
1) By Mammalian: Adherent Cells; Suspension Cells; Stem Cells
2) By Microbial: Bacterial Cells; Yeast Cells; Fungal Cells
3) By Other Cell Types: Plant Cells; Insect Cells; Hybridoma Cells


What New Market Trends Are Emerging in the Cell Expansion Market?
Major companies in the cell expansion market are prioritizing advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to enhance the efficiency and scalability of cell production for therapeutic applications. PluriCDMO provides large-scale, automated cell therapy manufacturing using a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development through clinical trials. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotechnology company, launched a new business division named PluriCDMO that will offer cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). The new division includes a 47,000-ft2 good manufacturing practice (GMP) cell therapy production facility. Through this new division, Pluri will offer services relating to early preclinical development through late-stage clinical trials and commercialization.

Who Are the Dominant Players Contributing Significantly to the Cell Expansion Market Revenue?
Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd., Worthington Industries Inc.

Get the detailed cell expansion market report today
https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Which Regions Are Expected to Record the Strongest CAGR in the Cell Expansion Market?
North America was the largest region in the cell expansion market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company